Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2011.12.17
关于更换保荐代表人的公告
2011.12.01
关于投资设立合资企业进展的公告
2011.12.01
关于公司高级管理人员辞职的公告
2011.11.03
关于控股子公司完成增资工商变更登记的公告
2011.11.03
关于向控股子公司提供委托贷款的进展公告
2011.10.19
中国建银投资证券有限责任公司关于公司有关委托贷款事项的核查意见
2011.10.19
关于向控股子公司提供委托贷款的公告
2011.10.19
第二届董事会第九次会议决议公告
2011.09.30
中国建银投资证券有限责任公司关于公司内部控制规则落实情况自查表及整改计划的核查意...
2011.09.30
关于内部控制规则落实情况自查报告和整改计划
第一页
上一页
140
141
142
143
144
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
